Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels
about
Meiotic interstrand DNA damage escapes paternal repair and causes chromosomal aberrations in the zygote by maternal misrepairNeed of cost-effective vaccines in developing countries: What plant biotechnology can offer?Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell CarcinomaCurrent Cervical Carcinoma Screening GuidelinesAdvances in targeted therapies and new promising targets in esophageal cancerEarly Defensive Mechanisms against Human Papillomavirus InfectionFollow-up to abnormal cancer screening tests: considering the multilevel context of careVIN usual type-from the past to the futureTwenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trAnnual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers.Trends in HPV cervical and seroprevalence and associations between oral and genital infection and serum antibodies in NHANES 2003-2012Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsementRadiological assessment of anal cancer: an overview and updatePopulation-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysisCross-Reactivity, Epitope Spreading, and De Novo Immune Stimulation Are Possible Mechanisms of Cross-Protection of Nonvaccine Human Papillomavirus (HPV) Types in Recipients of HPV Therapeutic VaccinesAre we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancersHuman Papillomavirus Infection, Infertility, and Assisted Reproductive OutcomesThe somatic genomic landscape of chromophobe renal cell carcinomaOpportunities for cancer prevention during midlife: highlights from a meeting of expertsGenotype directed therapy in murine mismatch repair deficient tumorsCapsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approachDiagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.Human papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancer.Isolation, Detection, and Quantification of Cancer Biomarkers in HPV-Associated Malignancies.Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.Comb-push ultrasound shear elastography (CUSE) for evaluation of thyroid nodules: preliminary in vivo results.Use of multiple imputation to correct for bias in lung cancer incidence trends by histologic subtype.Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.HPV vaccine uptake after introduction of the vaccine in Germany: an analysis of administrative data.Prostate Cancer Education, Detection, and Follow-Up in a Community-Based Multiethnic Cohort of Medically Underserved Men.Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival.The future point-of-care detection of disease and its data capture and handling.Prioritizing US Cervical Cancer Prevention With Results From a Geospatial Model.miR-375 activates p21 and suppresses telomerase activity by coordinately regulating HPV E6/E7, E6AP, CIP2A, and 14-3-3ζReverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer.Anal adenocarcinoma requires prophylactic inguinal nodal treatment: Results from a single Chinese institutionRecurrent respiratory papillomatosis: HPV genotypes and risk of high-grade laryngeal neoplasia
P2860
Q22121975-D1AB0672-A2E3-4383-AAE2-94AA20440291Q26769942-E264F280-93EC-47CB-9DE1-0700BFC81923Q26782499-A18B2E24-32A5-4B47-AE35-91ADA55C2F4EQ26799522-E8A66BA2-21D7-4E6D-91D3-84A5619CD43DQ26825957-882BCAEA-57F1-48A2-9409-CDA16ABD04B7Q26852611-32CBA045-5D3C-46A9-BB07-9E64F82A788EQ26861549-AA7D39A9-2272-450E-B9E0-D2FC91776537Q26865303-4506B18C-AEBC-4664-BD53-8970F79525C4Q27023862-68E73778-4DAE-4322-86FC-769B0D0134E1Q27300459-C6B533B3-1B12-4152-9230-2C797EBD3E28Q27302754-056C6AD1-4A4C-468A-A489-668088A0972FQ27312453-8AE1246E-63DF-4855-85A9-B46907C1E4B2Q27345076-D56E3BFF-23B1-4E89-9225-7AC83FAEF81EQ28069669-7B67A333-277A-4BAE-B1A8-1F0DF9CCA15CQ28079785-9EB8E213-0758-442B-BEB4-F65A668D9D6FQ28084924-C0ED0F6F-E5C8-4950-9757-BB84E02FA489Q28085724-AD7D4FA6-1E42-4C46-8227-7619DFC183FFQ28088322-3771D11B-8853-4DAB-AE66-92E32495C7A2Q28088327-3B3ED69D-1F2D-46D0-9ECA-6B761B62ED13Q28246658-4AB99BDB-6A04-4DBA-AA84-E1CA5E5C736CQ28385723-061E8BEF-7809-46C4-AD1D-F218995CFDD6Q28534803-5C717B51-2BCC-46D5-B3D6-88BF684663A7Q28607775-16A5D73B-A11E-474B-877F-9FFA4C596626Q30241076-5CC8886C-D81D-4747-818A-B625B1ACB3A6Q30251408-4D78147B-E161-4D74-80EC-014F07D61180Q30301333-481DC59A-F73F-4C0C-BE20-919C6DE579A4Q30354272-07C284AC-F73C-44AC-920C-0FD35D109B8CQ30354637-5963AC93-EA53-4317-AAAE-84E2AAC4056BQ30421762-04577214-858B-4069-AF1E-D07525107FBDQ30585673-68766B3D-1269-40C2-91EE-BD98605448A1Q30746254-1D39D0A9-729E-4792-BF8D-387447D07CC5Q30779875-63339B1C-1472-49B0-BAA5-B820EE15F21CQ30791985-06E3F224-D1BF-4337-91ED-F9B49DE56E16Q30847275-7C40662A-63F9-435A-B616-D2E2A2B747D3Q31037656-6C043FCA-BF68-49BF-A411-9ECF8C1CDAB5Q33557289-D0D6F868-0899-4B3C-B09E-292FC1381024Q33614271-9A12F55A-2D70-4C88-8605-3BC3622C3B3DQ33637161-7DB75AA7-F28D-4DA8-8743-1D31B254FA2BQ33702377-B47E2F22-FBC7-44F6-A737-EC14C4517469Q33740343-8F6238CF-D12A-4DE2-A2A2-2B3C8FD1A4AF
P2860
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Annual Report to the Nation on ...... PV vaccination coverage levels
@ast
Annual Report to the Nation on ...... PV vaccination coverage levels
@en
type
label
Annual Report to the Nation on ...... PV vaccination coverage levels
@ast
Annual Report to the Nation on ...... PV vaccination coverage levels
@en
prefLabel
Annual Report to the Nation on ...... PV vaccination coverage levels
@ast
Annual Report to the Nation on ...... PV vaccination coverage levels
@en
P2093
P2860
P50
P356
P1476
Annual Report to the Nation on ...... PV vaccination coverage levels
@en
P2093
Ahmedin Jemal
Anne-Michelle Noone
Betsy Kohler
Brenda K Edwards
Christie Eheman
Christina Dorell
David Yankey
Debbie Saslow
Edgar P Simard
Kathleen A Cronin
P2860
P304
P356
10.1093/JNCI/DJS491
P407
P577
2013-01-07T00:00:00Z